+41 91 682 20 40
info@elixi-int.com
Reserved Area

Home
About Us
Services
Quality
News
Case Studies
Contact
Online Store

Let's talk

info@yourwebsite.com
+1 (555) 123-4567

Search

small cell lung cancer

14 February 2021

Cosela (trilaciclib), first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression